Clinical Trials · NCT02454543

Impact of Radical Prostatectomy as Primary Treatment in Patients With Prostate Cancer With Limited Bone Metastases

Active Not RecruitingN/AGonadorelin (Investigational)
Phase
N/A
Recruitment status
Active Not Recruiting
Sponsor
Martini-Klinik am UKE GmbH
Enrollment
452
Start date
May 2015
Locations
1 site, Germany
Primary endpoint
Cancer specific survival
View Gonadorelin compound reference